1,3-dipropyl-8-cyclopentylxanthine has been researched along with Cancer of Pancreas in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verspohl, EJ | 1 |
| Johannwille, B | 1 |
| Waheed, A | 1 |
| Neye, H | 1 |
| Eidelman, O | 1 |
| Guay-Broder, C | 1 |
| van Galen, PJ | 1 |
| Jacobson, KA | 1 |
| Fox, C | 1 |
| Turner, RJ | 1 |
| Cabantchik, ZI | 1 |
| Pollard, HB | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Cancer of Pancreas
| Article | Year |
|---|---|
Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets.
Topics: Adenosine Deaminase; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cell Line; Estrenes; Fe | 2002 |
A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells.
Topics: 2-Chloroadenosine; Adenocarcinoma; Adenosine; Cell Line; Chlorides; Chromosome Deletion; Colonic Neo | 1992 |